XML 17 R6.htm IDEA: XBRL DOCUMENT v3.22.2.2
Consolidated Statements of Changes in Stockholders' Equity - USD ($)
$ in Thousands
Total
Preferred stock
Common stock
Additional paid-in capital
Retained earnings
Accumulated other comprehensive income (loss)
Treasury stock
Total stockholders' equity attributable to parent
Noncontrolling interest
Beginning balance (in shares) at Dec. 31, 2020   733              
Beginning balance (in shares) at Dec. 31, 2020     12,374,322            
Beginning balance (in shares) at Dec. 31, 2020             848,016    
Beginning balance at Dec. 31, 2020 $ 239,483 $ 7,334 $ 12,374 $ 129,119 $ 105,171 $ 2,226 $ (16,741) $ 239,483 $ 0
Increase (Decrease) in Stockholders' Equity                  
Net income (loss) 8,058       8,085     8,085 (27)
Other comprehensive loss (4,118)         (4,118)   (4,118)  
Dividends on common stock (1,153)       (1,153)     (1,153)  
Dividends on preferred stock (35)       (35)     (35)  
Stock-based compensation 592     592       592  
Redemption of preferred stock (in shares)   (733)              
Redemption of preferred stock (7,334) $ (7,334)           (7,334)  
Common stock options exercised (in shares)     52,584            
Common stock options exercised 690   $ 53 637       690  
Restricted stock units issued (in shares)     11,155            
Restricted stock units issued 0   $ 11 (11)       0  
Noncontrolling interests due to acquisition 500               500
Ending balance (in shares) at Mar. 31, 2021   0              
Ending balance (in shares) at Mar. 31, 2021     12,438,061            
Ending balance (in shares) at Mar. 31, 2021             848,016    
Ending balance at Mar. 31, 2021 236,683 $ 0 $ 12,438 130,337 112,068 (1,892) $ (16,741) 236,210 473
Beginning balance (in shares) at Dec. 31, 2020   733              
Beginning balance (in shares) at Dec. 31, 2020     12,374,322            
Beginning balance (in shares) at Dec. 31, 2020             848,016    
Beginning balance at Dec. 31, 2020 239,483 $ 7,334 $ 12,374 129,119 105,171 2,226 $ (16,741) 239,483 0
Increase (Decrease) in Stockholders' Equity                  
Net income (loss) 28,895                
Other comprehensive loss (3,041)                
Common stock issued related to acquisitions 708                
Ending balance (in shares) at Sep. 30, 2021   0              
Ending balance (in shares) at Sep. 30, 2021     12,820,220            
Ending balance (in shares) at Sep. 30, 2021             848,016    
Ending balance at Sep. 30, 2021 266,700 $ 0 $ 12,820 140,235 130,066 (815) $ (16,741) 265,565 1,135
Beginning balance (in shares) at Mar. 31, 2021   0              
Beginning balance (in shares) at Mar. 31, 2021     12,438,061            
Beginning balance (in shares) at Mar. 31, 2021             848,016    
Beginning balance at Mar. 31, 2021 236,683 $ 0 $ 12,438 130,337 112,068 (1,892) $ (16,741) 236,210 473
Increase (Decrease) in Stockholders' Equity                  
Net income (loss) 9,163       9,247     9,247 (84)
Other comprehensive loss 1,891         1,891   1,891  
Dividends on common stock (1,405)       (1,405)     (1,405)  
Stock-based compensation 692     692       692  
Common stock options exercised (in shares)     108,511            
Common stock options exercised 1,607   $ 108 1,499       1,607  
Restricted stock units issued (in shares)     57,906            
Restricted stock units issued 0   $ 58 (58)       0  
Minimum tax withholding on restricted stock units issued (231)     (231)       (231)  
Common stock issued related to acquisition (in shares)     17,597            
Common stock issued related to acquisitions 600   $ 18 582       600  
Noncontrolling interests due to acquisition 400               400
Ending balance (in shares) at Jun. 30, 2021   0              
Ending balance (in shares) at Jun. 30, 2021     12,622,075            
Ending balance (in shares) at Jun. 30, 2021             848,016    
Ending balance at Jun. 30, 2021 249,400 $ 0 $ 12,622 132,821 119,910 (1) $ (16,741) 248,611 789
Increase (Decrease) in Stockholders' Equity                  
Net income (loss) 11,674       11,828     11,828 (154)
Other comprehensive loss (814)         (814)   (814)  
Dividends on common stock (1,672)       (1,672)     (1,672)  
Stock-based compensation 1,055     1,055       1,055  
Common stock options exercised (in shares)     64,399            
Common stock options exercised 1,108   $ 64 1,044       1,108  
Restricted stock units issued (in shares)     1,410            
Restricted stock units issued 0   $ 1 (1)       0  
Minimum tax withholding on restricted stock units issued (25)     (25)       (25)  
Common stock issued related to stock-based compensation (in shares)     24,408            
Common stock issued related to contingent consideration 1,000   $ 25 975       1,000  
Common stock issued related to equity method investment (in shares)     107,928            
Common stock issued related to equity method investment 4,474   $ 108 4,366       4,474  
Noncontrolling interests due to acquisition 500               500
Ending balance (in shares) at Sep. 30, 2021   0              
Ending balance (in shares) at Sep. 30, 2021     12,820,220            
Ending balance (in shares) at Sep. 30, 2021             848,016    
Ending balance at Sep. 30, 2021 $ 266,700 $ 0 $ 12,820 140,235 130,066 (815) $ (16,741) 265,565 1,135
Beginning balance (in shares) at Dec. 31, 2021   0              
Beginning balance (in shares) at Dec. 31, 2021 12,086,950   12,934,966            
Beginning balance (in shares) at Dec. 31, 2021             848,016    
Beginning balance at Dec. 31, 2021 $ 275,303 $ 0 $ 12,935 143,521 138,219 (3,606) $ (16,741) 274,328 975
Increase (Decrease) in Stockholders' Equity                  
Net income (loss) 2,671       2,864     2,864 (193)
Other comprehensive loss (13,556)         (13,556)   (13,556)  
Dividends on common stock (2,059)       (2,059)     (2,059)  
Stock-based compensation 674     674       674  
Stock-based compensation related to equity method investment 104     104       104  
Common stock options exercised (in shares)     56,174            
Common stock options exercised 725   $ 56 669       725  
Ending balance (in shares) at Mar. 31, 2022   0              
Ending balance (in shares) at Mar. 31, 2022     12,991,140            
Ending balance (in shares) at Mar. 31, 2022             848,016    
Ending balance at Mar. 31, 2022 $ 263,862 $ 0 $ 12,991 144,968 139,024 (17,162) $ (16,741) 263,080 782
Beginning balance (in shares) at Dec. 31, 2021   0              
Beginning balance (in shares) at Dec. 31, 2021 12,086,950   12,934,966            
Beginning balance (in shares) at Dec. 31, 2021             848,016    
Beginning balance at Dec. 31, 2021 $ 275,303 $ 0 $ 12,935 143,521 138,219 (3,606) $ (16,741) 274,328 975
Increase (Decrease) in Stockholders' Equity                  
Net income (loss) 8,017                
Other comprehensive loss (36,371)                
Common stock issued related to acquisitions $ 0                
Ending balance (in shares) at Sep. 30, 2022   0              
Ending balance (in shares) at Sep. 30, 2022 12,286,935   13,134,951            
Ending balance (in shares) at Sep. 30, 2022             848,016    
Ending balance at Sep. 30, 2022 $ 244,360 $ 0 $ 13,135 146,950 140,546 (39,977) $ (16,741) 243,913 447
Beginning balance (in shares) at Mar. 31, 2022   0              
Beginning balance (in shares) at Mar. 31, 2022     12,991,140            
Beginning balance (in shares) at Mar. 31, 2022             848,016    
Beginning balance at Mar. 31, 2022 263,862 $ 0 $ 12,991 144,968 139,024 (17,162) $ (16,741) 263,080 782
Increase (Decrease) in Stockholders' Equity                  
Net income (loss) 2,791       2,956     2,956 (165)
Other comprehensive loss (12,258)         (12,258)   (12,258)  
Dividends on common stock (2,076)       (2,076)     (2,076)  
Stock-based compensation 757     757       757  
Stock-based compensation related to equity method investment 173     173       173  
Common stock options exercised (in shares)     30,200            
Common stock options exercised 392   $ 30 362       392  
Restricted stock units issued (in shares)     73,300            
Restricted stock units issued 0   $ 73 (73)       0  
Minimum tax withholding on restricted stock units issued (in shares)     (17,596)            
Minimum tax withholding on restricted stock units issued (691)   $ (17) (674)       (691)  
Stock purchase from noncontrolling interest (40)     (33)       (33) (7)
Ending balance (in shares) at Jun. 30, 2022   0              
Ending balance (in shares) at Jun. 30, 2022     13,077,044            
Ending balance (in shares) at Jun. 30, 2022             848,016    
Ending balance at Jun. 30, 2022 252,910 $ 0 $ 13,077 145,480 139,904 (29,420) $ (16,741) 252,300 610
Increase (Decrease) in Stockholders' Equity                  
Net income (loss) 2,555       2,718     2,718 (163)
Other comprehensive loss (10,557)         (10,557)   (10,557)  
Dividends on common stock (2,076)       (2,076)     (2,076)  
Stock-based compensation 671     671       671  
Stock-based compensation related to equity method investment 139     139       139  
Common stock options exercised (in shares)     55,853            
Common stock options exercised 718   $ 56 662       718  
Restricted stock units issued (in shares)     2,054            
Restricted stock units issued $ 0   $ 2 (2)       0  
Ending balance (in shares) at Sep. 30, 2022   0              
Ending balance (in shares) at Sep. 30, 2022 12,286,935   13,134,951            
Ending balance (in shares) at Sep. 30, 2022             848,016    
Ending balance at Sep. 30, 2022 $ 244,360 $ 0 $ 13,135 $ 146,950 $ 140,546 $ (39,977) $ (16,741) $ 243,913 $ 447